Seminars in Oncology

Papers
(The median citation count of Seminars in Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
KRAS mutation in pancreatic cancer95
Axillary surgery in breast cancer: An updated historical perspective59
Systemic therapy for metastatic HER2-positive breast cancer50
Just eat it: A review of CD47 and SIRP-α antagonism48
Are sex discordant outcomes in COVID-19 related to sex hormones?41
Implications of reactive oxygen species on cancer formation and its treatment33
Breast cancer survivorship31
Cancer diagnosis in Brazil in the COVID-19 era30
The evolving management of metastatic triple negative breast cancer28
Novel radiation therapy approaches for breast cancer treatment28
Chemotherapy-induced peripheral neuropathy and rehabilitation: A review27
Homologous recombination repair deficiency as a therapeutic target in sarcoma26
Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center24
Management of hormone receptor-positive, HER2-negative early breast cancer24
Early stage triple negative breast cancer: Management and future directions23
Management of ER positive metastatic breast cancer22
Going viral: A brief history of Chilblain-like skin lesions (“COVID toes”) amidst the COVID-19 pandemic21
COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature16
Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review13
Harnessing natural killer cells for the treatment of multiple myeloma12
Combination therapy in metastatic renal cell carcinoma: Back to the future?11
Radiation recall dermatitis: A review of the literature11
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma tre11
Can locally developed me-too drugs aid price negotiation? An example of cancer therapies from China11
A review of immune checkpoint blockade in breast cancer10
Irreversible electroporation of locally advanced pancreatic cancer10
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management10
Novel targeted therapies for advanced non-small lung cancer10
The heterogeneity of Epithelioid Hemangioendothelioma (EHE): A case series and review of the literature with emphasis on treatment options10
Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview10
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-1910
Current controversies in breast cancer screening9
Therapeutic potential of isatuximab in the treatment of multiple myeloma: Evidence to date9
Liquid Biopsy, the hype vs. hope in molecular and clinical oncology9
Future directions in drug development in pancreatic cancer9
Radiotherapy for locally advanced pancreatic ductal adenocarcinoma9
The importance of Epstein-Barr virus infection in the systemic treatment of patients with gastric cancer8
COVID-19 and the cancer care workforce: From doctors to ancillary staff8
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer8
Pancreatic ductal adenocarcinoma in the era of precision medicine8
Management problems in patients with pancreatic cancer from a surgeon's perspective8
Neoadjuvant chemotherapy for gastric cancer. Has the time to decelerate the enthusiasm passed us by?8
Ocular metastases from neuroendocrine tumors: A literature review7
Metabolic targeting can improve the efficiency of brain tumor biopsies7
Depression in women with a diagnosis of breast cancer. Prevalence of symptoms of depression in Peruvian women with early breast cancer and related sociodemographic factors6
Pathogenic signaling in multiple myeloma6
Landmark trials in the medical oncology management of early stage breast cancer6
Immune checkpoints and their inhibitors: Reappraisal of a novel diagnostic and therapeutic dimension in the urologic malignancies6
Two decades of research toward the treatment of locally advanced and metastatic pancreatic cancer: Remarkable effort and limited gain6
Barriers and facilitators to lung cancer screening and follow-up5
Advances and current concepts in reconstructive surgery for breast cancer5
Impact of CT screening in lung cancer: Scientific evidence and literature review5
The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma5
The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic review5
Future of immunotherapy in pancreas cancer and the trials, tribulations and successes thus far5
Epidemiology and genetics of early onset colorectal cancer—African overview with a focus on Ethiopia5
Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias5
Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers5
Non-pharmacologic interventions for improving cancer-related fatigue (CRF): A systematic review of systematic reviews and pooled meta-analysis4
A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective4
Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer4
Radiation oncology in times of COVID-2019: A review article for those in the eye of the storm – An Indian perspective4
A systematic review with in silico analysis on transcriptomic profile of gallbladder carcinoma4
Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing—The experience of a large oncology center in t4
“Off-the-shelf” immunotherapies for multiple myeloma4
Daratumumab: A review of current indications and future directions4
Landmark trials in the medical oncology management of metastatic breast cancer4
Military exposures and lung cancer in United States Veterans4
Treatment sequencing of metastatic colorectal cancer based on primary tumor location4
Complete response in a frail patient with high-grade B-cell lymphoma to only one cycle of R-CHOP or to prolonged COVID-19?4
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics4
The Impact of HIV on Non-AIDS defining gastrointestinal malignancies: A review4
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations4
COVID 19 pandemic testing time – Crisis or opportunity in disguise for India?3
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review3
The impact of the COVID-19 pandemic on tertiary care cancer center: Analyzing administrative data3
COVID-19 and Cancer in Cuba3
Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?3
Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study3
Gemcitabine plus nab‐paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in Veterans3
Rare SARS-CoV-2 antibody development in cancer patients3
Distribution of cancer genes in human chromosomes3
Preservation of fertility in female: Indications, available options, and current status in Saudi Arabia3
Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer3
The knowns and unknowns of disparities, biology, and clinical outcomes in Hispanic and Latinx multiple myeloma patients in the U.S.3
Positive attitudes toward clinical trials among military veterans leaves unanswered questions about poor trial accrual2
Treatment and outcomes of pediatric patients with cancer and COVID-19 at MAHAK pediatric cancer treatment and research center, Tehran, Iran2
Loss of function STK11 alterations and poor outcomes in non–small-cell lung cancer: Literature and case series of US Veterans2
Modern radiographic imaging in multiple myeloma, what is the minimum requirement?2
Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized con2
Lung cancer screening at the VA: Past, present and future2
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.2
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab2
Comorbidity and life expectancy in shared decision making for lung cancer screening2
IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time2
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action2
Examining health related quality of life outcomes in multiple myeloma: Past and future perspectives2
Skin metastases in the clinical and dermoscopic aspects2
Optimizing the treatment algorithm for sentinel lymph node mapping in endometrial cancer2
Current and prospective antibody-based therapies in multiple myeloma2
Molecular biomarkers and liquid biopsies in lung cancer2
Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use2
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy2
Management of early breast cancer in patients bearing germline BRCA mutations2
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis2
Torticollis as a presenting symptom of pediatric CNS tumors: A systematic review2
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects2
Management strategy for cancer patients in the context of the COVID-19 epidemic2
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans2
Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma?1
PARP inhibitors for prostate cancer1
Practical guidance for new multiple myeloma treatment regimens: A nursing perspective1
Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC)1
Germline mutations of the E-cadherin gene (CDH1) in early onset gastric cancer1
Masthead1
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance1
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA1
Outcomes with panobinostat in heavily pretreated multiple myeloma patients1
Lung cancer: Premalignant biology and medical prevention1
Non-small cell lung cancer in the era of immunotherapy1
Masthead1
Scoping to analyze oncology trial participation in Australia1
Predictors of treatment refusal in patients with colorectal cancer: A systematic review1
Communication strategies during the COVID-19 pandemic: Unforeseen opportunities and drawbacks1
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)1
Exploring the effects of racial and socioeconomic factors on timeliness of lung cancer diagnosis and treatment in Baltimore Veterans1
Controversies and challenges in lung cancer screening1
Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program1
0.018815040588379